|
FOXN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.241990E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70125999999771E-05 |
| Normal-vs-Stage2 |
1.750190E-01 |
| Normal-vs-Stage3 |
9.530200E-01 |
| Normal-vs-Stage4 |
1.439160E-01 |
| Stage1-vs-Stage2 |
2.096000E-01 |
| Stage1-vs-Stage3 |
1.169400E-04 |
| Stage1-vs-Stage4 |
1.55566999999746E-05 |
| Stage2-vs-Stage3 |
1.616630E-01 |
| Stage2-vs-Stage4 |
2.436100E-02 |
| Stage3-vs-Stage4 |
1.888790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.541400E-03 |
| Normal-vs-AfricanAmerican |
6.197600E-01 |
| Normal-vs-Asian |
5.518400E-01 |
| Caucasian-vs-AfricanAmerican |
4.093800E-02 |
| Caucasian-vs-Asian |
8.542600E-01 |
| AfricanAmerican-vs-Asian |
3.343800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.258250E-02 |
| Normal-vs-Female |
9.271600E-02 |
| Male-vs-Female |
6.044400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.003400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.636300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.694600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.533000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.310600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.049600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.539400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.159500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.199800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.238610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.962500E-03 |
| Normal-vs-Grade 2 |
1.978530E-04 |
| Normal-vs-Grade 3 |
2.173800E-01 |
| Normal-vs-Grade 4 |
9.871900E-02 |
| Grade 1-vs-Grade 2 |
2.710200E-02 |
| Grade 1-vs-Grade 3 |
6.223600E-03 |
| Grade 1-vs-Grade 4 |
1.443890E-04 |
| Grade 2-vs-Grade 3 |
2.444500E-02 |
| Grade 2-vs-Grade 4 |
2.00839999999758E-05 |
| Grade 3-vs-Grade 4 |
1.736080E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.69209999532217E-08 |
| Normal-vs-ccB subtype |
3.031200E-01 |
| ccA subtype-vs-ccB subtype |
8.33500000000376E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.160400E-02 |
| Normal-vs-N1 |
1.831630E-01 |
| N0-vs-N1 |
4.715800E-02 |
|
|
